Merck & Co. faces a number of disputes with its insurersover coverage for the huge potential liability it faces stemmingfrom the Texas jury verdict in favor of the plaintiff in the firstVioxx product liability case.
According to the Whitehouse Station, N.J.-based company's 10-Qfiled for the second quarter of this year, the company has productliability coverage for claims brought in the Vioxx productliability lawsuits with stated upper limits of about $630 millionafter deductibles and co-insurance.
Vioxx is a painkiller, known as a Cox-2 inhibitor, primarilyused by people with arthritis.
Continue Reading for Free
Register and gain access to:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
